Interestingly, we found the tumour mutation burden was significantly elevated in TERT/ATRX-altered PCPG (One-tailed Student’s t-test p<0.001) consistent with a previous study11, but metastases from the TERT/ATRX wild type cases had a low mutation burden (Figure 6C). This evidence concerns the gene ATRX and neoplasm.